Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Histamine H3 receptor inhibitors, preparation and therapeutic uses

Histamine H3 receptor inhibitors, preparation and therapeutic uses

US Patent 7846950 · Granted Dec 7, 2010

Estimated economic value: $56,095,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes2022
Azetidinyloxyphenylpyrrolidine compounds2020
PDE1 inhibitor2018
6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA2016
Histamine H3 receptor agents, preparation and therapeutic uses2012
Histamine H3 receptor agents, preparation and therapeutic uses2011
Histamine H3 receptor agents, preparation and therapeutic uses2011
Pyrrolidine derivatives as histamine H3 receptor antagonists2011
Pyrrolidine derivatives as histamine H3 receptor antagonists2011
Histamine H3 receptor antagonists, preparation and therapeutic uses2011
Histamine H3 receptor agents, preparation and therapeutic uses2010
Histamine H3 receptor agents, preparation and therapeutic uses2010